Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 122341-38-2 Chemical Structure| 122341-38-2

Structure of Temoporfin
CAS No.: 122341-38-2

Chemical Structure| 122341-38-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Temoporfin is used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck.

Synonyms: m-THPC; KW2345; Foslipos

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Temoporfin

CAS No. :122341-38-2
Formula : C44H32N4O4
M.W : 680.75
SMILES Code : OC1=CC=CC(/C2=C3CCC(/C(C4=CC(O)=CC=C4)=C5C=C/C(N/5)=C(C6=CC(O)=CC=C6)/C(C=C/7)=NC7=C(C8=CC(O)=CC=C8)/C9=CC=C2N9)=N\3)=C1
Synonyms :
m-THPC; KW2345; Foslipos
MDL No. :MFCD00867835
InChI Key :LYPFDBRUNKHDGX-UHFFFAOYSA-N
Pubchem ID :60751

Safety of Temoporfin

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P264-P270-P301+P310-P321-P330-P405-P501
Class:6.1
UN#:2811
Packing Group:

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00003856 Head and Neck Cancer Phase 2 Unknown - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 United States, Florida H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Illinois Division of Head and Neck Surgery Evanston, Illinois, United States, 60201 United States, Kentucky Norton Healthcare Pavilion Louisville, Kentucky, United States, 40202 United States, Minnesota Ear, Nose, and Throat Specialty Care of Minnesota, P.A. Minneapolis, Minnesota, United States, 55404 United States, New York School of Dental Medicine Buffalo, New York, United States, 14214-3008 St. Luke's-Roosevelt Hospital New York, New York, United States, 10019 Less <<
NCT01086488 Nasopharyngeal Carcinoma Phase 2 Unknown October 2011 Malaysia ... More >> Hospital Universiti Sains Malaysia Not yet recruiting Kubang Kerian, Kelantan, Malaysia, 16150 Contact: Baharudin Abdullah, MD    0139825050    baharudin@kb.usm.my    Contact: Biswal Mohan, MD    +6097653370       Queen Elizabeth Hospital Not yet recruiting Kota Kinabalu, Sabah, Malaysia Contact: Chee Lun Lum, MD    +6088318605       Contact: Jayendran Dharmaratnam, MD    +6088438512    navinsurfer@hotmail.com    Universiti Malaysia Sarawak Not yet recruiting Kuching, Sarawak, Malaysia, 93150 Contact: Thung Sing Tiong, MD    +6082422564       Contact: Vignes Tharumalingam, MD    01620900002       Kuala Lumpur Hospital Recruiting Kuala Lumpur, Malaysia, 53000 Contact: Yoke Yeow Yap, MD    +60320501001    yokeyeow@yahoo.com    Contact: Azura Deniel, MD    +60326925713    azurahkl@yahoo.com    Hospital Pulau Pinang Not yet recruiting Penang, Malaysia Contact: Kin Choo Pua, MD    +6044105463    puakinchoo@pph.moh.gov.my Less <<
NCT01718223 Recurrent Squamous Cell Carcin... More >>oma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Verrucous Carcinoma of the Oral Cavity Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity Stage I Squamous Cell Carcinoma of the Oropharynx Stage I Verrucous Carcinoma of the Oral Cavity Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity Stage II Squamous Cell Carcinoma of the Oropharynx Stage II Verrucous Carcinoma of the Oral Cavity Tongue Cancer Less << Not Applicable Withdrawn(implementation issue... More >>s) Less << - -
NCT01016002 Non-curative Resectable Bile D... More >>uct Carcinoma Less << Phase 2 Unknown - Austria ... More >> Department of Internal Medicine I, Paracelsus Medical University Salzburg Recruiting Salzburg, Austria, 5020 Contact: Frieder Berr, Prof., MD       f.berr@salk.at    Principal Investigator: Frieder Berr, Prof., MD          Germany Internal Medicine Dept., University Medical Center Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: A. Lohse, Prof., MD       alohse@uke-uni-hamburg.de    Principal Investigator: A. Lohse, Prof., MD Less <<
NCT01637376 Carcinoma, Non-Small-Cell-Lung Phase 1 Withdrawn(No participants were... More >> enrolled) Less << - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT01854684 Recurrent Non-Small Cell Lung ... More >>Carcinoma Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Non-Small Cell Lung Cancer Less << Phase 1 Suspended(Expiration of drug) December 30, 2018 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Less <<
NCT01415986 Squamous Cell Carcinoma of the... More >> Head and Neck Less << Phase 2 Terminated(The patient was "lo... More >>st to follow-up" and the PI left the institution.) Less << - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT01415986 - Terminated(The patient was "lo... More >>st to follow-up" and the PI left the institution.) Less << - -
NCT03003065 Cholangiocarcinoma ... More >> Tumor Klatskin Tumor Less << Phase 2 Recruiting August 2019 Hong Kong ... More >> Endoscopy Centre, Prince of Wales Hospital Recruiting Shatin, N.t., Hong Kong Contact: Kim WL AU, MSc    +85226322640    kimau@surgery.cuhk.edu.hk Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.47mL

0.29mL

0.15mL

7.34mL

1.47mL

0.73mL

14.69mL

2.94mL

1.47mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories